Mary Van Beusekom | News Writer | CIDRAP NewsMay 28, 2020An international study found similar results with either a 5-day or 10-day course of the antiviral drug.
5 days of remdesivir for COVID-19 may be enough
Published in COVID-19
More from COVID-19More posts in COVID-19 »
- During pandemic, ivermectin use rose 10-fold, hydroxychloroquine use doubled, study reveals
- ACIP postponement, shelving of CDC vaccine campaigns stir fears
- US flu still high, COVID low but elevated in some areas, RSV declining, CDC says
- Data suggest Paxlovid doesn’t reduce severe COVID in older, vaccinated adults